Comment
Author: Admin | 2025-04-28
The only oral retinoid approved by the U.S. Food and Drug Administration (FDA) specifically for treating psoriasis.The exact way Soriatane works to control psoriasis is unknown. In general, retinoids help control the multiplication of cells, including the speed at which skin cells grow and shed. Learn more about Soriatane (acitretin).Sotyktu selectively targets the immune system by inhibiting tyrosine kinase 2 (TYK2), a member of the Janus kinase (JAK) family. Sotyktu is approved for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Learn more about Sotyktu.Aimed at reducing psoriatic arthritis inflammation, Xeljanz targets a specific part of the immune system (Janus kinase) to reduce the overactive response associated with psoriatic disease. The oral treatment also aids in reducing joint tenderness and swelling. Learn more about Xeljanz and Xeljanz XR.Help is Here for YouNPF Patient Navigatiors can answer your questions about oral treatments, including understanding their side effects and helping assess potential risks.Contact the Patient Navigation CenterLast updated on 11/2/23 by the National Psoriasis Foundation.
Add Comment